photo of working crossword puzzle in comfort

By Raj Maturi, MD as told to Rachel Reiff Ellis

Geographic atrophy (GA) is the loss of a thin but critical layer of cells in your retina. The retina is the light-sensitive tissue at the back of the eye. Even though this layer of cells is very thin, it’s critical for vision. 

These cells line your rod and cone photoreceptors, which are the parts of your eye that help you see in low light, see sharply in brighter light, and see color. When you have GA, these cells waste away and die. 

Adapting to Vision Loss

Although you’ll keep your peripheral vision, the blind spot in your central visual field caused by GA can make day-to-day activities like driving, cooking, reading, and even recognizing faces difficult. Luckily, if you have low vision, there are rehabilitation services available.

Vision rehabilitation is different from eye examination and diagnosis of problems. A rehabilitation team focuses on helping you find ways to keep doing your daily activities even with vision loss. They take stock of what vision you have, as well as what you need to do each day. 

They can introduce you to tools to help you accomplish those tasks. Some of the most common low-vision tools include magnifiers, special glasses, electronic devices, and smartphone apps. 

The American Academy of Ophthalmology website provides information and tips for low-vision living. The devices that help you will depend on your specific needs. But in general, you want to adopt practices and adapt your home to increase contrast, reduce glare, and improve lighting overall. 

Your smartphone is a ready-made vision assistance tool, too. You can adjust the font to be larger on your screen, and make the contrast higher. You can use talk-to-text to send messages, and have your phone read texts aloud.

Some apps provide object identification and narrate the world around you when you point your phone or tablet toward it. Other apps connect you with real people who can help with daily tasks such as reading labels. AI is learning new ways to help people “see” better every day with tools like facial recognition that reads emotion for you.

Hope in New Treatments

Although GA isn’t currently curable, the future of its treatment is hopeful. Two new medications are available for some patients with GA: avacincaptad pegol (Izervay) and pegcetacoplan (Syfovre). Both are medications a doctor injects into your eye once a month. The goal with these injections is to hopefully slow your disease. 

These drugs don’t improve your vision, but they can slow the progression of your GA. Ask your ophthalmologist if these treatments are right for you. 

A newer therapy for dry age-related macular degeneration (AMD) just got FDA clearance. GA is an advanced form of dry AMD. The new treatment is a light therapy that seems to slow the start of GA and preserve your central vision by about three to four letters over two years. Valeda is the company developing this therapy. Some data is still needed, as it seems to be most beneficial in a very small segment of the population – those with vision loss and minimal GA. 

Show Sources

Photo Credit: E+/Getty Images

SOURCE:

Raj Maturi, MD, clinical spokesperson, American Academy of Ophthalmology.

DPM1000222

Font size :
Audio audio